Leukaemia treatment depends above all on the type of leukaemia. Acute leukaemias usually need prompt, intensive chemotherapy in hospital, sometimes followed by a stem cell transplant. Chronic leukaemias are often controlled for years with targeted tablets, and some early cases need no treatment at all, just careful monitoring. This guide explains the main options, how treatment is structured, and what patients and families can expect along the way.
Leukaemia is a cancer of the blood-forming cells in the bone marrow. The marrow fills with abnormal white blood cells that crowd out healthy red cells, white cells, and platelets. Treatment aims to clear those abnormal cells and let normal blood production recover.
Why the Type of Leukaemia Shapes Treatment
Doctors classify leukaemia along two lines. Acute leukaemias grow quickly from immature cells called blasts, while chronic leukaemias progress more slowly from more mature cells. They are also split by cell family: myeloid or lymphoid (lymphocytic).
| Type | Who it usually affects | Main treatment approach |
|---|---|---|
| Acute myeloid leukaemia (AML) | Mostly older adults | Intensive chemotherapy, targeted drugs for specific mutations, stem cell transplant for higher-risk disease; lower-intensity combinations for less fit patients |
| Acute lymphoblastic leukaemia (ALL) | Most common leukaemia in children; also adults | Multi-phase chemotherapy lasting around two to three years, central nervous system treatment, immunotherapy for some |
| Chronic myeloid leukaemia (CML) | Mainly adults | Daily tyrosine kinase inhibitor tablets targeting the BCR-ABL protein |
| Chronic lymphocytic leukaemia (CLL) | Older adults | Active monitoring if early and symptom-free; targeted tablets or antibody combinations when treatment is needed |
Beyond the broad type, the specialist team looks at genetic and chromosomal changes in the leukaemia cells, the patient’s age, fitness, and other health conditions. These details decide both the intensity of treatment and which targeted drugs might help.
The Main Treatment Options
Chemotherapy
Chemotherapy uses drugs that kill rapidly dividing cells. It remains the backbone of treatment for acute leukaemias. It is usually given through a central line in the chest or arm, often as several drugs combined, and sometimes into the spinal fluid to protect the brain and spinal cord in ALL.
Targeted Therapy
Targeted therapies block specific proteins that drive leukaemia cells. Imatinib and related tyrosine kinase inhibitors transformed CML from a fatal disease into one that most people now manage with daily tablets. In AML, drugs targeting mutations such as FLT3 or IDH are added for patients whose leukaemia carries them. In CLL, BTK inhibitors and the BCL-2 inhibitor venetoclax are widely used.
Immunotherapy
Immunotherapy helps the immune system recognise and destroy leukaemia cells. Examples include monoclonal antibodies, bispecific antibodies such as blinatumomab for B-cell ALL, and CAR T-cell therapy, in which a patient’s own T cells are engineered to attack the leukaemia. These are mostly used when leukaemia has relapsed or not responded to standard treatment.
Stem Cell Transplant
An allogeneic stem cell transplant replaces the patient’s blood-forming system with healthy cells from a matched donor. High-dose treatment clears the marrow first, and the donor’s immune cells then help attack any remaining leukaemia. It offers the best chance of cure for some higher-risk acute leukaemias, but carries significant risks, including infection and graft-versus-host disease, so it is reserved for patients likely to benefit.
Other Treatments
Radiotherapy is occasionally used, for example before transplant or to treat leukaemia in specific sites. Acute promyelocytic leukaemia, a special subtype of AML, is treated with all-trans retinoic acid (ATRA) combined with arsenic trioxide and has an excellent outlook when treated promptly.
The Phases of Acute Leukaemia Treatment
Acute leukaemia treatment is delivered in stages, each with a different goal.
- Induction: intensive treatment, usually in hospital for several weeks, aimed at achieving remission, meaning no visible leukaemia in the blood or marrow.
- Consolidation (intensification): further courses to destroy remaining leukaemia cells that tests cannot yet see, reducing the risk of relapse.
- Maintenance: used mainly in ALL, this involves lower-intensity treatment, often tablets, given for up to two years or more.
Response is tracked with blood counts, bone marrow tests, and sensitive tests for minimal residual disease (MRD), which can detect tiny numbers of leukaemia cells. MRD results often guide whether treatment should be intensified or a transplant considered.
Managing Side Effects and Supportive Care
Supportive care is as important as the anti-leukaemia drugs themselves. Because treatment temporarily wipes out normal blood cells, patients are vulnerable to infection, anaemia, and bleeding.
- Infection: fever during low neutrophil counts (neutropenic fever) is a medical emergency that needs urgent antibiotics. Preventive antibiotics, antifungals, and antivirals are often given.
- Anaemia and bleeding: red cell and platelet transfusions support patients until the marrow recovers.
- Tumour lysis syndrome: when many leukaemia cells die at once, they release salts and uric acid that can harm the kidneys. Fluids and medicines such as allopurinol help prevent it.
- Nausea, mouth sores, hair loss, and fatigue: managed with anti-sickness medicines, mouth care, and rest.
- Fertility: some treatments affect fertility, so options for preserving it should be discussed before starting.
A balanced diet, gentle activity as tolerated, food hygiene during low counts, and psychological support all help patients cope. These measures do not treat the leukaemia but improve quality of life and resilience through treatment.
When to See a Doctor
The symptoms of leukaemia include persistent tiredness, repeated infections, fevers, easy bruising or bleeding, night sweats, weight loss, and swollen lymph nodes. See a doctor promptly if these persist; a simple blood count is usually the first step.
If you are already on treatment, contact your treating team immediately for a temperature of 38°C or higher, shivering, new bleeding, breathlessness, or feeling suddenly unwell. Most leukaemia units provide a 24-hour hotline for exactly this reason.
Frequently Asked Questions
Can leukaemia be cured?
Many people are cured, especially children with ALL and some adults with acute leukaemia who respond well or undergo transplant. Chronic leukaemias are often not cured but can be controlled for many years. Your specialist can explain the outlook for your specific type and genetic profile.
How long does leukaemia treatment last?
It varies widely. Intensive AML treatment typically spans several months. ALL treatment, including maintenance, usually lasts two to three years. CML and CLL tablets may be taken long term, though some CML patients in deep, sustained remission can stop under close supervision.
Why do some CLL patients not get treatment straight away?
Early CLL often causes no symptoms and progresses slowly. Starting treatment early in such cases has not been shown to help, so doctors use “watch and wait” monitoring and begin therapy when symptoms or blood count changes appear.
Will I need a stem cell transplant?
Not necessarily. Transplant is recommended mainly for acute leukaemia with high-risk features, persistent MRD, or relapse, in patients fit enough to tolerate it. Many people are treated successfully without one.
For more on every type of leukaemia, diagnosis, and outlook, see our complete leukaemia guide.
